Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
Clinical trial NCT04610229 · COMPLETED
Trial details
- NCT number
- NCT04610229
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2019-08-12
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.